Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mol Cell Oncol (2015) 2(3):e992217
For facial use, limit it to 2 minutes
Acknowledgements The authors thank their funding agencies, the Singapore Ministry of Health, Ministry of Education and Ministry of Trade, the National Medical Research Council, Singapore, and the Singapore Agency for Science, Technology and Research, for grants NMRC/CSA/0054/2013 (P.M.Y.), NMRC/BNIG/2025/2014 (R.A.S.), IA/I/16/2/502691-Wellcome Trust/DBT India Alliance Intermediate Fellowship (R.A.S.) and NMRC/OFYIRG/0002/2016 (B.K.S.)
Current treatment landscape for relapsed and/or refractory multiple myeloma
Mostly certain growth hormone secretagogues, some antimicrobial peptides, and a few melanocortin-related compounds
Research indicates that 1% is the clinical "sweet spot" for mature skin
US$ 25.20
US$ 23.54
US$ 28.49
US$ 23.46
US$ 26.70
US$ 21.80
US$ 27.00
US$ 29.17
